Beacon Pointe Advisors, LLC Vertex Pharmaceuticals Inc Transaction History

Beacon Pointe Advisors, LLC

  • $8.35 Billion
  • Q2 2024

A detailed history of Beacon Pointe Advisors, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Beacon Pointe Advisors, LLC holds 19,181 shares of VRTX stock, worth $9.64 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
19,181
Previous 19,189 0.04%
Holding current value
$9.64 Million
Previous $8.02 Million 12.08%
% of portfolio
0.11%
Previous 0.09%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024
SELL
$392.81 - $485.53 $3,142 - $3,884
-8 Reduced 0.04%
19,181 $8.99 Million
Q1 2024

May 14, 2024
SELL
$407.69 - $446.08 $30,576 - $33,456
-75 Reduced 0.39%
19,189 $8.02 Million
Q4 2023

Feb 08, 2024
SELL
$343.0 - $410.68 $278,859 - $333,882
-813 Reduced 4.05%
19,264 $7.84 Million
Q3 2023

Nov 14, 2023
BUY
$338.18 - $362.46 $244,842 - $262,421
724 Added 3.74%
20,077 $6.98 Million
Q2 2023

Aug 11, 2023
SELL
$314.42 - $351.91 $551,178 - $616,898
-1,753 Reduced 8.31%
19,353 $6.81 Million
Q1 2023

May 12, 2023
SELL
$283.23 - $323.1 $1.48 Million - $1.69 Million
-5,230 Reduced 19.86%
21,106 $6.65 Million
Q4 2022

Feb 14, 2023
SELL
$285.76 - $321.48 $156,024 - $175,528
-546 Reduced 2.03%
26,336 $7.61 Million
Q3 2022

Nov 09, 2022
SELL
$273.83 - $305.53 $81,327 - $90,742
-297 Reduced 1.09%
26,882 $7.79 Million
Q2 2022

Aug 11, 2022
SELL
$234.96 - $292.55 $176,924 - $220,290
-753 Reduced 2.7%
27,179 $7.66 Million
Q1 2022

May 17, 2022
BUY
$221.42 - $260.97 $1.2 Million - $1.41 Million
5,414 Added 24.04%
27,932 $7.29 Million
Q4 2021

Feb 14, 2022
SELL
$177.01 - $223.45 $1.12 Million - $1.41 Million
-6,314 Reduced 21.9%
22,518 $4.95 Million
Q3 2021

Nov 15, 2021
BUY
$181.39 - $202.99 $3.24 Million - $3.62 Million
17,845 Added 162.42%
28,832 $5.23 Million
Q2 2021

Aug 17, 2021
BUY
$187.49 - $221.1 $1.79 Million - $2.11 Million
9,536 Added 657.2%
10,987 $2.22 Million
Q1 2021

May 18, 2021
BUY
$207.02 - $241.31 $14,491 - $16,891
70 Added 5.07%
1,451 $313,000
Q4 2020

Feb 12, 2021
SELL
$207.01 - $276.09 $37,882 - $50,524
-183 Reduced 11.7%
1,381 $327,000
Q3 2020

Nov 16, 2020
BUY
$255.65 - $303.1 $41,415 - $49,102
162 Added 11.55%
1,564 $426,000
Q2 2020

Aug 14, 2020
BUY
$225.48 - $295.8 $2,931 - $3,845
13 Added 0.94%
1,402 $408,000
Q1 2020

May 15, 2020
BUY
$199.77 - $247.81 $277,480 - $344,208
1,389 New
1,389 $329,000

Others Institutions Holding VRTX

# of Institutions
1,716
Shares Held
225M
Call Options Held
1.19M
Put Options Held
1.56M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $129B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Beacon Pointe Advisors, LLC Portfolio

Follow Beacon Pointe Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Beacon Pointe Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Beacon Pointe Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email